Myocardial neovascularization by adult bone marrow-derived angioblasts: Strategies for improvement of cardiomyocyte function

Heart Failure Reviews

Volumn 8, Issue 3, 2003, Pages 253-258

  Itescu, Silviu ^a   Kocher, Alfred A ^a   Schuster, Michael D ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AC133 PROTEIN; ACTININ; ALPHA4 INTEGRIN; ANGIOPOIETIN; ANGIOPOIETIN RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; AZACITIDINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BLOOD CLOTTING FACTOR 8; CD31 ANTIGEN; CD34 ANTIGEN; CYTOKINE; DESMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL CELL GROWTH FACTOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GRANULOCYTE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; NITRIC OXIDE SYNTHASE; PROTEIN; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR GATA 3; TROPONIN I; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; VON WILLEBRAND FACTOR;

ADOPTIVE IMMUNOTHERAPY; ANGIOGENESIS; AORTA; APOPTOSIS; BONE MARROW; CAPILLARY; CELL FUNCTION; CELL POPULATION; CELL REGENERATION; EMBRYO CELL; EMBRYO DEVELOPMENT; ENDOTHELIUM; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HEMANGIOBLAST; HEMATOPOIESIS; HUMAN; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; NUTRIENT; OXYGEN SUPPLY; PHENOTYPE; PRENATAL PERIOD; PROTEIN EXPRESSION; REVIEW; STEM CELL;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL TRANSPLANTATION; HEART FAILURE, CONGESTIVE; HUMANS; INCIDENCE; MYOBLASTS, CARDIAC; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PATHOLOGIC; UNITED STATES;

EID: 0043065385     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024721717926     Document Type: Review

References (45)

1. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) Trial Study Group. N Engl J Med 1987;316(23):1429-1435.
2. Mahon NG, O'Roke C, Codd MB, et al. Hospital mortality of acute myocardial infarction in the thrombolytic era. Heart 1999;81:478-482.
3. Hognes JR. In The Artificial Heart: Prototypes, Policies and Patients. Washington, DC: National Academy Press, 1991:1-312.
4. Annual Report of the US Scientific Registry for Organ Transplantation and the Organ Procurement and Transplantation Network, 1990. Washington, DC: US Department of Health and Human Services, 1990.
5. Frazier OH, Rose EA, Macmanus Q, et al. Multicenter clinical evaluation of the Heartmate 1000 IP left ventricular assist device. Ann Thorac Surg 1992;102:578-587.
6. McCarthy PM, Rose EA, Macmanus Q, et al. Clinical experience with the Novacor ventricular assist system. J Thorac Cardiovasc Surg 1991;102:578-587.
7. Oz MC, Argenziano M, Catanase KA, et al. Bridge experience with long-term implantable left ventricular assist devices. Are they an alternative to transplantation. Circulation 1997;95(7):1844-1852.
8. Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol 1997;80(11A):15L-25L.
9. Ravichandran LV, Puvanakrishnan R. In vivo labeling studies on the biosynthesis and degradation of collagen in experimental myocardial infarction. Biochem Intl 1991;24:405-414.
10. Agocha A, Lee H-W, Eghali-Webb M. Hypoxia regulates basal and induced DNA synthesis and collagen type I production in human cardiac fibroblasts: Effects of TGF-beta, thyroid hormone, angiotensin II and basic fibroblast growth factor. J Mol Cell Cardiol 1997;29:2233-2244H.
11. Pfeffer JM, Pfeffer MA, Fletcher PJ, Braunwald E. Progressive ventricular remodeling in rat with myocardial infarction. Am J Physiol 1991;260:H1406-H14014.
12. White HD, Norris RM, Brown MA, Brandt PWT, Whitlock RML, Wild CJ. Left ventricular end systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987;76:44-51.
13. Nelissen-Vrancken H, Debets J, Snoeckx L, Daemen M, Smits J. Time-related normalization of maximal coronary flow in isolated perfused hearts of rats with myocardial infarction. Circulation 1996;93:349-355.
14. Kalkman EAJ, Bilgin YM, Van Haren P, Van Suylen R-J, Saxena PR, Schoemaker RG. Determinants of coronary reserve in rats subjected to coronary artery ligation or aortic banding. Cardiovasc Res 1996.
15. Heymans S, Luutun A, Nuyens D, et al. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 1999;5:1135-1142.
16. Hochman JS, Choo H. Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. Circulation 1987;75:299-306.
17. White HD, Cross DB, Elliot JM, et al. Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for myocardial infarction. Circulation 1994;89:61-67.
18. Nidorf SM, Siu SC, Galambos G, Weyman AE, Picard MH. Benefit of late coronary reperfusion on ventricular morphology and function after myocardial infarction. J Am Coll Cardiol 1992;20:307-313.
19. Tavian M, Coulombel L, Luton D, San Clemente H, Dieterlen-Lievre F, Peault B. Aorta-associated CD34 hematopoietic cells in the early human embryo. Blood 1996;87:67-72.
20. Jaffredo T, Gautier R, Eichmann A, Dieterlen-Lievre F. Intraaortic hemopoietic cells are derived from endothelial cells during ontogeny. Development 1998;125:4575-4583.
21. Kennedy M, Firpo M, Choi K, Wall C, Robertson S, Kabrun N, Keller G. A common precursor for primitive erythropoiesis and definitive haematopoiesis. Nature 1997;386:488-493.
22. Choi K, Kennedy M, Kazarov A, Papadimitriou Keller G. A common precursor for hematopoietic and endothelial cells. Development 1998;125:725-732.
23. Elefanty AG, Robb L, Birner R, Begley CG. Hematopoietic-specific genes are not induced during in vitro differentiation of scl-null embryonic stem cells. Blood 1997;90:1435-1447.
24. Labastie M-C, Cortes F, Romeo P-H, Dulac C, Peault B. Molecular identity of hematopoietic precursor cells emerging in the human embryo. Blood 1998;92:3624-3635.
25. Tsai FY, Keller G, Kuo FC, Weiss M, Chen J, Rosenblatt M, Alt FA, Orkin SH. An early hematopoietic defect in mice lacking the transcription factor GATA-2. Nature 1994;371:221-225.
26. Ogawa M, Kizumoto M, Nishikawa S, Fujimoto T, Kodama H, Nishikawa SI. Blood 1999;93:1168-1177.
27. Asahara T, et al. Isolation of putative progenitor cells for endothelial angiogenesis. Science 1997;275:964-967.
28. Folkman J. Therapeutic angiogenesis in ischemic limbs. Circulation 1998;97:108-110.
29. Takahashi T, et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999;5:434-438.
30. Kalka C, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000;97:3422-3427.
31. Rafii S, Shapiro F, Rimarachin J, Nachman R, Ferris B, Weksler B, Moore AS, Asch AS. Isolation and characterization of human bone marrow microvascular endothelial cells: Hematopoietic progenitor cell adhesion. Blood 1994;84:10-19.
32. Shi Q, Rafii S, Wu MH-D, et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998;92:362-367.
33. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000;105:71-77.
34. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, Itescu S. Neovascularization of ischemic myocardium by human bone marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nature Med 2001;7:430-436.
35. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999;18:3964-3972.
36. Makino S, Fukuda K, Miyoshi S, et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999;103:697-705.
37. Tomita S, Li R-K, Weisel RD, et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 1999;100:II-247.
38. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
39. Liechty KW, MacKenzie TC, Shaaban AF, et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 2000;6:1282-1286.
40. Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, Gepstein A, Livne E, Binah O, Itskovitz-Eldor J, Gepstein L. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 2001;108:407-414.
41. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-705.
42. McEwan PE, Gray GA, Sherry L, Webb DJ, Kenyon CJ. Differential effects of angiotensin II on cardiac cell proliferation and intramyocardial perivascular fibrosis in vivo. Circulation 1998;98:2765-2773.
43. Kawano H, Do YS, Kawano Y, Starnes V, Barr M, Law RE, Hsueh WA. Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts. Circulation 2000;101:1130-1137.
44. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE investigators. N Engl J Med 1993;327:669-677.
45. Pitt B, Segal R, Martinez FA, et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 1997;349:747-752.